• The Metropolitan District (MDC) is continuing the final phase of a district-wide, eight-town program to install automated meter reading devices at each location presently connected to the MDC water distribution system. In coordination with its supplier, Itron Inc. and its installation contractor, Utility Partners of America (UPA), the MDC will install approximately 30,000 automated meter reading devices for customers in the towns of East Hartford, West Hartford, Rocky Hill and Farmington. (Installation of the devices in Wethersfield, Newington, Hartford, Bloomfield and Windsor customers has already been completed under the initial phase of the project.) This program will implement industry standard automation technology that is proven to significantly reduce estimated water bills, increase billing accuracy and eliminate the need to routinely access customer homes to read water meters.
• MidState Medical Center’s Cancer Center has been accredited as a National Breast Center of Excellence by the American College of Surgeons. National Breast Center accreditation is given to institutions that voluntarily undergo a rigorous evaluation process and review of their performance for best-practice standards. During the lengthy application process, MidState Medical Center demonstrated its proficiency in leadership, clinical management, research, community outreach, professional education, and quality improvement.
• At its annual dinner, the Avon Volunteer Fire Department (AVFD) presented Avon-based Reflexite with the Corporate Citizen Appreciation Award for the company’s ongoing support of the AVFD through the provision of reflective fire safety products such as helmet patches, high-temp fire tape, prismatic vinyl letters and numbers, and prismatic graphic sheeting for vehicle visibility.
• Dr. Kenneth Weisman, a urologist at MidState Medical Center in Meriden, was asked to represent Hybridyne Imaging Technologies at the prestigious R&D 100 Awards. Each year, R&D Magazine honors the most promising inventions and new products in various categories. Dr. Weisman was asked to represent Hybridyne for his work on a new device that can localize cancer within the prostate gland, which was until now not possible.
Please Note: All electronic submissions for Accolades should be sent to news@HartfordBusiness.com. Items can also be mailed to: Accolades, Hartford Business Journal, 15 Lewis St., Suite 200, Hartford, CT 06103. For more information about the Hartford Business Journal’s Accolades Page, please visit www.HartfordBusiness.com.
